SHARE

Novo Nordisk launches first daily oral GLP-1 weight-loss pill Wegovy in UK pharmacies

Novo Nordisk’s Wegovy pill, the first daily oral GLP-1 for weight management, is now available in UK retail and online pharmacies. Approved by NICE, it expands obesity treatment options for adults via private providers.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.